IL86457A - Immunoglobulins AGI and GGI of human-specific cancer-related vectors produced by human-human hybridomas using B cells in liver cancer and lineage - Google Patents

Immunoglobulins AGI and GGI of human-specific cancer-related vectors produced by human-human hybridomas using B cells in liver cancer and lineage

Info

Publication number
IL86457A
IL86457A IL8645788A IL8645788A IL86457A IL 86457 A IL86457 A IL 86457A IL 8645788 A IL8645788 A IL 8645788A IL 8645788 A IL8645788 A IL 8645788A IL 86457 A IL86457 A IL 86457A
Authority
IL
Israel
Prior art keywords
human
cells
hybridoma
liver cancer
antigen
Prior art date
Application number
IL8645788A
Other languages
English (en)
Hebrew (he)
Other versions
IL86457A0 (en
Original Assignee
Hagiwara Yoshihide
Hagiwara Hideaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hagiwara Yoshihide, Hagiwara Hideaki filed Critical Hagiwara Yoshihide
Publication of IL86457A0 publication Critical patent/IL86457A0/xx
Publication of IL86457A publication Critical patent/IL86457A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL8645788A 1987-05-23 1988-05-20 Immunoglobulins AGI and GGI of human-specific cancer-related vectors produced by human-human hybridomas using B cells in liver cancer and lineage IL86457A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62126687A JPH0798000B2 (ja) 1987-05-23 1987-05-23 ガン関連抗原特異的ヒト免疫グロブリン

Publications (2)

Publication Number Publication Date
IL86457A0 IL86457A0 (en) 1988-11-15
IL86457A true IL86457A (en) 1994-07-31

Family

ID=14941365

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8645788A IL86457A (en) 1987-05-23 1988-05-20 Immunoglobulins AGI and GGI of human-specific cancer-related vectors produced by human-human hybridomas using B cells in liver cancer and lineage

Country Status (9)

Country Link
US (1) US5093261A (fr)
EP (1) EP0293155B1 (fr)
JP (1) JPH0798000B2 (fr)
KR (1) KR930012104B1 (fr)
AU (1) AU628288B2 (fr)
CA (1) CA1340880C (fr)
DE (1) DE3851571T2 (fr)
ES (1) ES2064349T3 (fr)
IL (1) IL86457A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223842B1 (en) 1986-08-11 2007-05-29 Massachusetts Eye And Ear Infirmary Detection of proteins whose absence is associated with a neoplasm
US7384735B1 (en) 1986-08-11 2008-06-10 Massachusetts Eye And Ear Infirmary Retinoblastoma nucleic acids
JPH0798000B2 (ja) * 1987-05-23 1995-10-25 萩原 義秀 ガン関連抗原特異的ヒト免疫グロブリン
US6787153B1 (en) 1991-06-28 2004-09-07 Mitsubishi Chemical Corporation Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
CA2072249C (fr) * 1991-06-28 2003-06-17 Saiko Hosokawa Anticorps monoclonal humain liant specifiquement a la surface d'un antigene des membranes des cellules cancereuses
US6197582B1 (en) * 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
AUPR177400A0 (en) * 2000-11-29 2000-12-21 Cancerprobe Pty Ltd Probes for identifying cancer-specific antigens
TW200303919A (en) 2001-12-05 2003-09-16 Hiroyuki Ohno Cytotoxic protein and the use
DE10311248A1 (de) * 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
US20060141482A1 (en) * 2004-12-23 2006-06-29 Awdalla Essam T Method and multicomponent conjugates for treating cancer
US20070179105A1 (en) * 2006-01-31 2007-08-02 Awdalla Essam T Method and means for treating solid tumors
US20070178107A1 (en) * 2006-01-31 2007-08-02 Awdalla Essam T Method and means for treating solid tumors
US20070178104A1 (en) * 2006-01-31 2007-08-02 Awdalla Essam T Methods and means for treating solid tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618577A (en) * 1983-02-09 1986-10-21 The Regents Of The University Of California Human-human hybridoma, CLNH5
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS6058093A (ja) * 1983-09-12 1985-04-04 Asahi Chem Ind Co Ltd 抗癌ヒト抗体の産生方法
JPS6115897A (ja) * 1984-06-29 1986-01-23 Suntory Ltd ヒト肝癌細胞を特異的に認識するモノクロ−ナル抗体
JPS6144900A (ja) * 1984-08-08 1986-03-04 Green Cross Corp:The モノクロ−ナル抗体及び癌抗原検出用試薬
US4761377A (en) * 1984-10-15 1988-08-02 The Regents Of The University Of California Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells
US4693975A (en) * 1984-11-20 1987-09-15 The Wistar Institute Human hybridroma fusion partner for production of human monoclonal antibodies
JPS6251983A (ja) * 1985-09-02 1987-03-06 Hagiwara Yoshihide ヒト／ヒト・ハイブリド−マ培養用無血清培地
EP0222360A3 (fr) * 1985-11-12 1989-03-15 Biotherapeutics Inc. Procédé de production d'un réactif cytotoxique spécifique du patient et composition
JPH0798000B2 (ja) * 1987-05-23 1995-10-25 萩原 義秀 ガン関連抗原特異的ヒト免疫グロブリン
US4942123A (en) * 1987-09-17 1990-07-17 The Regents Of The University Of California ppRB110 -phosphoprotein the retinoblastoma susceptibility gene product
US5536571A (en) * 1993-07-02 1996-07-16 Congoleum Corporation Release coating

Also Published As

Publication number Publication date
AU628288B2 (en) 1992-09-17
KR930012104B1 (ko) 1993-12-24
JPH0798000B2 (ja) 1995-10-25
EP0293155A2 (fr) 1988-11-30
DE3851571T2 (de) 1995-03-09
DE3851571D1 (de) 1994-10-27
EP0293155B1 (fr) 1994-09-21
CA1340880C (fr) 2000-01-25
AU1654588A (en) 1989-11-23
JPS63290898A (ja) 1988-11-28
KR880014109A (ko) 1988-12-22
US5093261A (en) 1992-03-03
EP0293155A3 (en) 1989-07-12
IL86457A0 (en) 1988-11-15
ES2064349T3 (es) 1995-02-01

Similar Documents

Publication Publication Date Title
EP0014519B1 (fr) Lignées de cellules, procédé pour leur préparation et procédé pour la production d'anticorps
EP0293155B1 (fr) Immunoglobulines humaines spécifiques de l'antigène relatif au cancer et hybridomes humains-humains pouvant produire ces immunoglobulines humaines
JPH0159878B2 (fr)
IE870487L (en) Lung carcinoma antigen and antibody
EP0232871A2 (fr) Anticorps monoclonal humain, hybridome le produisant et son utilisation
JPS59137497A (ja) 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
EP0057107A2 (fr) Procédé de préparation d'anticorps monoclonaux et cellules aptes à produire ces anticorps
US5106738A (en) Tumor specific monoclonal antibodies
Baldwin et al. Monoclonal antibodies specifying tumour-associated antigens and their potential for therapy
EP0363703B1 (fr) Procédé de production d'hybridomes humain-humain, production d'anticorps monoclonaux ou polyclonaux à partir de ceux-ci, et leur utilisation thérapeutique
US5030564A (en) Monoclonal antibody specific to the lymphokine LK 2 and its method of production
JP2599123B2 (ja) 新規なヒトｂセル・リンパ芽球細胞変異株
YOSHIKAWA et al. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique
JP2509191B2 (ja) ガン関連抗原特異的ヒト免疫グロブリン
JP2599258B2 (ja) ガン関連抗原特異的ヒト免疫グロブリン生産性ヒト／ヒトハイブリドーマ
JP2721817B2 (ja) ヒト／ヒト・ハイブリドーマ及びその生産する抗体
JPH05268988A (ja) ガン関連抗原特異的ヒト免疫グロブリン
JPH0829078B2 (ja) ガン関連抗原特異的ヒト免疫グロブリン生産性ヒト／ヒトハイブリドーマ
JP2830976B2 (ja) 癌関連抗原特異的ヒト免疫グロブリン
Brown The Production of Monoclonal Antibodies by Cell Fusion
JPH07119240B2 (ja) 抗原特異的ヒト免疫グロブリン
McKearn et al. Mapping of Novel B Lymphocyte Differentiation Antigens
JPS6270400A (ja) ガン関連抗原特異的ヒト免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPH01500722A (ja) 膵臓α‐アミラーゼに対する抗体の産生及び診断への使用
JPH07121221B2 (ja) 抗原特異的ヒト免疫グロブリン生産性ヒト／ヒトハイブリドーマ

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees